{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:19:07Z","timestamp":1784636347671,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Educational Trust Fund, Bayero University Kano"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anaemia is a common presenting feature among patients with chronic kidney disease (CKD) and it is associated with poor clinical outcomes and quality of life. It is not clear if growth differentiation factor-15 (GDF-15) or hepcidin are useful as early markers of iron deficiency anaemia (IDA) among non-dialysis CKD patients. We therefore evaluated the diagnostic validity of GDF-15 and hepcidin as biomarkers of IDA among non-dialysis CKD patients in Johannesburg, South Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      An analytic cross-sectional study was conducted among non-dialysis CKD patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009312) and apparently healthy controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009184) from June to December 2016 at an Academic Hospital, in Johannesburg, South Africa. An interviewer administered proforma was used to obtain the socio-biological and clinical characteristics of the participants. Serum levels of GDF-15 and hepcidin were determined. Predictive logistic regression models were built and post estimation receiver operator characteristics were determined to evaluate diagnostic validity of hepcidin and GDF-15 for absolute and functional iron deficiency anaemia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      About half (50.6%) of the participants were female while the participants\u2019 mean age was 49.7\u2009\u00b1\u200915.8\u2009years. The predictive value of diagnosing absolute IDA among CKD patients using GDF-15 was 74.02% (95% CI: 67.62\u201380.42%) while the predictive value of diagnosing functional IDA among CKD patients using hepcidin was 70.1% (95% CI: 62.79\u201377.49%).There was a weak negative correlation between hepcidin levels and GFR (r\u2009=\u2009\u2212\u20090.19,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04) in anaemic CKD patients, and between serum GDF-15 and haemoglobin (r\u2009=\u2009\u2212\u20090.34,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Serum ferritin (\u03b2\u2009=\u20090.00389,\n                      <jats:italic>P<\/jats:italic>\n                      -value&lt;\u20090.001), was a predictor of log hepcidin. MCHC (\u03b2\u2009=\u2009\u2212\u20090.0220,\n                      <jats:italic>P<\/jats:italic>\n                      -value 0.005) and CKD stage (\u03b2\u2009=\u20090.4761, P-value &lt;\u20090.001), race (\u03b2\u2009=\u20090.3429, P-value\u2009=\u20090.018) were predictors of log GDF-15. Both GDF-15 (adj OR: 1.0003, 95%CI: 1.0001\u20131.0005,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.017) and hepcidin (adj OR: 1.003, 95%CI: 1.0004\u20131.0055,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.023) were associated with iron deficiency anaemia after multiple linear regression modelling.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum GDF-15 is a potential biomarker of absolute IDA, while hepcidin levels can predict functional IDA among CKD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-02046-7","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T06:04:21Z","timestamp":1601359461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3662-8150","authenticated-orcid":false,"given":"Aishatu M.","family":"Nalado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbenga","family":"Olorunfemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Dix-Peek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dickens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lungile","family":"Khambule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Snyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Paget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Mahlangu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saraladevi","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"2046_CR1","doi-asserted-by":"crossref","unstructured":"Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J, et al. Renal association clinical practice guideline on Anaemia of chronic kidney disease. BMC Nephrol. 2017;18.","DOI":"10.1186\/s12882-017-0688-1"},{"issue":"2","key":"2046_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1681\/ASN.2006070802","volume":"18","author":"T Ganz","year":"2007","unstructured":"Ganz T. Molecular control of iron transport. J Am Soc Nephrol. 2007;18(2):394\u2013400.","journal-title":"J Am Soc Nephrol"},{"issue":"5704","key":"2046_CR3","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science (New York, NY). 2004;306(5704):2090\u20133.","journal-title":"Science (New York, NY)"},{"issue":"Suppl 1","key":"2046_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/ijlh.12358","volume":"37","author":"J Arezes","year":"2015","unstructured":"Arezes J, Nemeth E. Hepcidin and iron disorders: new biology and clinical approaches. Int J Lab Hematol. 2015;37(Suppl 1):92\u20138.","journal-title":"Int J Lab Hematol"},{"issue":"12","key":"2046_CR5","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1182\/blood-2006-06-028787","volume":"108","author":"M Pak","year":"2006","unstructured":"Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 2006;108(12):3730\u20135.","journal-title":"Blood."},{"issue":"1","key":"2046_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10238-010-0102-9","volume":"11","author":"PP Cheng","year":"2011","unstructured":"Cheng PP, Jiao XY, Wang XH, Lin JH, Cai YM. Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med. 2011;11(1):33\u201342.","journal-title":"Clin Exp Med"},{"issue":"1","key":"2046_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5045\/br.2013.48.1.10","volume":"48","author":"G D'angelo","year":"2013","unstructured":"D'angelo G. Role of hepcidin in the pathophysiology and diagnosis of anemia. Blood Res. 2013;48(1):10\u20135.","journal-title":"Blood Res"},{"issue":"3","key":"2046_CR8","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/ndt\/gfr431","volume":"27","author":"T Uehata","year":"2012","unstructured":"Uehata T, Tomosugi N, Shoji T, Sakaguchi Y, Suzuki A, Kaneko T, et al. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study. Nephrology Dialysis Transplantation. 2012;27(3):1076\u201383.","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"2046_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1744-9987.12001","volume":"17","author":"K Tsuchiya","year":"2013","unstructured":"Tsuchiya K, Nitta K. Hepcidin is a potential regulator of iron status in chronic kidney disease. Ther Apheresis Dial. 2013;17(1):1\u20138.","journal-title":"Ther Apheresis Dial"},{"issue":"3","key":"2046_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MOH.0000000000000236","volume":"23","author":"C-Y Wang","year":"2016","unstructured":"Wang C-Y, Babitt JL. Hepcidin regulation in the anemia of inflammation. Curr Opin Hematol. 2016;23(3):189.","journal-title":"Curr Opin Hematol"},{"key":"2046_CR11","doi-asserted-by":"publisher","unstructured":"Yalcin MM, Altinova AE, Akturk M, Gulbahar O, Arslan E, Ors Sendogan D, et al. GDF-15 and Hepcidin levels in nonanemic patients with impaired glucose tolerance. J Diabetes Res. 2016. https:\/\/doi.org\/10.1155\/2016\/1240843.","DOI":"10.1155\/2016\/1240843"},{"issue":"21","key":"2046_CR12","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","volume":"94","author":"MR Bootcov","year":"1997","unstructured":"Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A. 1997;94(21):11514\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2046_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1240843","volume":"2016","author":"AEA Mehmet Muhittin Yalcin","year":"2016","unstructured":"Mehmet Muhittin Yalcin AEA, Akturk M, et al. GDF-15 and Hepcidin levels in nonanemic patients with impaired glucose tolerance. J Diabetes Res. 2016;2016:1\u20135.","journal-title":"J Diabetes Res"},{"issue":"5","key":"2046_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1515\/cclm-2013-0769","volume":"52","author":"L Valenti","year":"2014","unstructured":"Valenti L, Messa P, Pelusi S, Campostrini N, Girelli D. Hepcidin levels in chronic hemodialysis patients: a critical evaluation. Clin Chem Lab Med. 2014;52(5):613\u20139.","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"2046_CR15","first-page":"387","volume":"52","author":"T Tanno","year":"2011","unstructured":"Tanno T, Miller JL. [GDF15 expression and iron overload in ineffective erythropoiesis]. [Rinsho ketsueki]. Japanese J Clin Hematol. 2011;52(6):387\u201398.","journal-title":"Japanese J Clin Hematol"},{"issue":"7","key":"2046_CR16","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1182\/blood-2008-07-170431","volume":"113","author":"S Lakhal","year":"2009","unstructured":"Lakhal S, Talbot NP, Crosby A, Stoepker C, Townsend AR, Robbins PA, et al. Regulation of growth differentiation factor 15 expression by intracellular iron. Blood. 2009;113(7):1555\u201363.","journal-title":"Blood."},{"issue":"1","key":"2046_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7123\/01.EJH.0000423012.78137.2e","volume":"38","author":"HM Abaza","year":"2013","unstructured":"Abaza HM, Habashy DM, El-Nashar RE. Growth differentiation factor 15 expression in anemia of chronic disease and iron deficiency anemia. Egyptian J Haematology. 2013;38(1):23.","journal-title":"Egyptian J Haematology"},{"issue":"10","key":"2046_CR18","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/ajh.24820","volume":"92","author":"MD Cappellini","year":"2017","unstructured":"Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CS, et al. Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management. Am J Hematol. 2017;92(10):1068\u201378.","journal-title":"Am J Hematol"},{"issue":"Suppl 1","key":"2046_CR19","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2215\/CJN.01490506","volume":"1","author":"JB Wish","year":"2006","unstructured":"Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006;1(Suppl 1):S4\u20138.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"2046_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084943","volume":"9","author":"ME Stauffer","year":"2014","unstructured":"Stauffer ME, Fan T. Prevalence of Anemia in chronic kidney disease in the United States. PLoS One. 2014;9(1):e84943. https:\/\/doi.org\/10.1371\/journal.pone.0084943.","journal-title":"PLoS One"},{"issue":"10","key":"2046_CR21","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1093\/ndt\/gfr003","volume":"26","author":"JA van den Brand","year":"2011","unstructured":"van den Brand JA, van Boekel GA, Willems HL, Kiemeney LA, den Heijer M, Wetzels JF. Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2011;26(10):3176\u201381.","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"key":"2046_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/IJNRD.S179802","volume":"12","author":"AM Nalado","year":"2019","unstructured":"Nalado AM, Mahlangu JN, Waziri B, Duarte R, Paget G, Olorunfemi G, et al. Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa. Int J Nephrol Renovascular Dis. 2019;12:19.","journal-title":"Int J Nephrol Renovascular Dis"},{"issue":"3","key":"2046_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.vascn.2009.02.004","volume":"59","author":"H Li","year":"2009","unstructured":"Li H, Rose MJ, Tran L, Zhang J, Miranda LP, James CA, et al. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS\/MS. J Pharmacol Toxicol Methods. 2009;59(3):171\u201380.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"3","key":"2046_CR24","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1093\/ndt\/gfp546","volume":"25","author":"HP Peters","year":"2010","unstructured":"Peters HP, Laarakkers CM, Swinkels DW, Wetzels JF. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrology Dialysis Transpl. 2010;25(3):848\u201353.","journal-title":"Nephrology Dialysis Transpl"},{"issue":"9","key":"2046_CR25","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/ki.2009.21","volume":"75","author":"DR Ashby","year":"2009","unstructured":"Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int. 2009;75(9):976\u201381.","journal-title":"Kidney Int"},{"issue":"6","key":"2046_CR26","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2215\/CJN.05931108","volume":"4","author":"J Zaritsky","year":"2009","unstructured":"Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, et al. Hepcidin\u2014a potential novel biomarker for Iron status in chronic kidney disease. Clin J Am Soc Nephrology. 2009;4(6):1051\u20136.","journal-title":"Clin J Am Soc Nephrology"},{"issue":"9","key":"2046_CR27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/eurjhf\/hfq099","volume":"12","author":"K van der Putten","year":"2010","unstructured":"van der Putten K, Jie KE, van den Broek D, Kraaijenhagen RJ, Laarakkers C, Swinkels DW, et al. Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease\/chronic heart failure patients. Eur J Heart Fail. 2010;12(9):943\u201350.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"2046_CR28","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1182\/blood-2005-10-4043","volume":"108","author":"N Tomosugi","year":"2006","unstructured":"Tomosugi N, Kawabata H, Wakatabe R, Higuchi M, Yamaya H, Umehara H, et al. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip system. Blood. 2006;108(4):1381\u20137.","journal-title":"Blood."},{"issue":"5","key":"2046_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/gut.2003.022863","volume":"53","author":"H Kulaksiz","year":"2004","unstructured":"Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, et al. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut. 2004;53(5):735\u201343.","journal-title":"Gut."},{"issue":"7","key":"2046_CR30","doi-asserted-by":"publisher","first-page":"e39783","DOI":"10.1371\/journal.pone.0039783","volume":"7","author":"NC van der Weerd","year":"2012","unstructured":"van der Weerd NC, Grooteman MP, Bots ML, van den Dorpel MA, den Hoedt CH, Mazairac AH, et al. Hepcidin-25 in Chronic Hemodialysis Patients Is Related to Residual Kidney Function and Not to Treatment with Erythropoiesis Stimulating Agents. PLos One. 2012;7(7):e39783. https:\/\/doi.org\/10.1371\/journal.pone.0039783.","journal-title":"PLos One"},{"issue":"7","key":"2046_CR31","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1172\/JCI0215686","volume":"110","author":"G Nicolas","year":"2002","unstructured":"Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110(7):1037\u201344.","journal-title":"J Clin Invest"},{"issue":"10","key":"2046_CR32","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","volume":"112","author":"T Ganz","year":"2008","unstructured":"Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood. 2008;112(10):4292\u20137.","journal-title":"Blood."},{"key":"2046_CR33","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1093\/ndt\/gfn267","volume":"23","author":"WDWS JFM","year":"2008","unstructured":"JFM WDWS. Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? Nephrology Dialysis Transpl. 2008;23:2450\u20133.","journal-title":"Nephrology Dialysis Transpl"},{"issue":"3","key":"2046_CR34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/ki.2011.141","volume":"80","author":"DW Coyne","year":"2011","unstructured":"Coyne DW. Hepcidin: clinical utility as a diagnostic tool and therapeutic target. Kidney Int. 2011;80(3):240\u20134.","journal-title":"Kidney Int"},{"issue":"11","key":"2046_CR35","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.crohns.2014.04.008","volume":"8","author":"DR Ingo Mecklenburg","year":"2014","unstructured":"Ingo Mecklenburg DR, Reznik D, Fasler-Kan E, Drewe J, Beglinger C, Hruz P, et al. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease. J Crohns Colitis. 2014;8(11):1392\u20137. https:\/\/doi.org\/10.1016\/j.crohns.2014.04.008.","journal-title":"J Crohns Colitis"},{"key":"2046_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5812\/ircmj.17(5)2015.28343","volume":"17","author":"S Haghpanah","year":"2015","unstructured":"Haghpanah S, Esmaeilzadeh M, Honar N, Hassani F, Dehbozorgian J, Rezaei N, et al. Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern Iran. Iran Red Crescent Med J. 2015;17:7.","journal-title":"Iran Red Crescent Med J"},{"key":"2046_CR37","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1182\/blood.V124.21.4029.4029","volume":"124","author":"FAN BPE","year":"2014","unstructured":"BPE FAN, Ruiz MA, et al. Assessmet of Labile Plasma Iron and Hepcidin in Patients Who Undergo Hematopoietic Stem Cell Transplantation. Blood. 2014;124:4029.","journal-title":"Blood"},{"issue":"11","key":"2046_CR38","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/ajh.23519","volume":"88","author":"J Goyal","year":"2013","unstructured":"Goyal J, McCleskey B, Adamski J. Peering into the future: hepcidin testing. Am J Hematol. 2013;88(11):976\u20138.","journal-title":"Am J Hematol"},{"issue":"8","key":"2046_CR39","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3324\/haematol.2010.037960","volume":"96","author":"SR Pasricha","year":"2011","unstructured":"Pasricha SR, McQuilten Z, Westerman M, Keller A, Nemeth E, Ganz T, et al. Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica. 2011;96(8):1099\u2013105.","journal-title":"Haematologica."},{"issue":"7","key":"2046_CR40","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.18203\/2320-6012.ijrms20172546","volume":"5","author":"S Vyas","year":"2017","unstructured":"Vyas S, Kapoor A, Nema S, Suman S. Quantification of serum hepcidin as a potential biomarker in diagnosis of iron deficiency anaemia. Int J Res Med Sci. 2017;5(7):2926\u201330.","journal-title":"Int J Res Med Sci"},{"issue":"4","key":"2046_CR41","doi-asserted-by":"publisher","first-page":"286","DOI":"10.5045\/kjh.2012.47.4.286","volume":"47","author":"HS Choi","year":"2012","unstructured":"Choi HS, Song SH, Lee JH, Kim HJ, Yang HR. Serum hepcidin levels and iron parameters in children with iron deficiency. Korean J Hematol. 2012;47(4):286\u201392.","journal-title":"Korean J Hematol"},{"issue":"12","key":"2046_CR42","doi-asserted-by":"publisher","first-page":"e78964","DOI":"10.1371\/journal.pone.0078964","volume":"8","author":"FA Jonker","year":"2013","unstructured":"Jonker FA, Calis JC, Phiri K, Kraaijenhagen RJ, Brabin BJ, Faragher B, et al. Low hepcidin levels in severely anemic malawian children with high incidence of infectious diseases and bone marrow iron deficiency. PLoS One. 2013;8(12):e78964.","journal-title":"PLoS One"},{"issue":"5","key":"2046_CR43","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/bjh.12311","volume":"161","author":"DW Thomas","year":"2013","unstructured":"Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I, et al. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol. 2013;161(5):639\u201348.","journal-title":"Br J Haematol"},{"issue":"2","key":"2046_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12288-015-0551-0","volume":"32","author":"H Yilmaz","year":"2016","unstructured":"Yilmaz H, Cakmak M, Darcin T, Inan O, Bilgic MA, Bavbek N, et al. Can serum Gdf-15 be associated with functional Iron deficiency in hemodialysis patients? Indian J Hematol Blood Transfusion. 2016;32(2):221\u20137.","journal-title":"Indian J Hematol Blood Transfusion"},{"issue":"Pt 3","key":"2046_CR45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/0004563214552109","volume":"52","author":"XY Li","year":"2015","unstructured":"Li XY, Ying J, Li JH, Zhu SL, Li J, Pai P. Growth differentiation factor GDF-15 does not influence iron metabolism in stable chronic haemodialysis patients. Ann Clin Biochem. 2015;52(Pt 3):399\u2013403.","journal-title":"Ann Clin Biochem"},{"issue":"2","key":"2046_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-2141.2008.07441.x","volume":"144","author":"JM Ramirez","year":"2009","unstructured":"Ramirez JM, Schaad O, Durual S, Cossali D, Docquier M, Beris P, et al. Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts. Br J Haematol. 2009;144(2):251\u201362.","journal-title":"Br J Haematol"},{"issue":"7","key":"2046_CR47","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/j.1537-2995.2010.02601.x","volume":"50","author":"T Tanno","year":"2010","unstructured":"Tanno T, Rabel A, Lee YT, Yau YY, Leitman SF, Miller JL. Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation. Transfusion. 2010;50(7):1532\u20135.","journal-title":"Transfusion."},{"issue":"10","key":"2046_CR48","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1111\/j.1537-2995.2008.01823.x","volume":"48","author":"AE Mast","year":"2008","unstructured":"Mast AE, Foster TM, Pinder HL, Beczkiewicz CA, Bellissimo DB, Murphy AT, et al. Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors. Transfusion. 2008;48(10):2197\u2013204.","journal-title":"Transfusion."},{"key":"2046_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1371\/journal.pone.0204899","volume":"13","author":"AM Nalado","year":"2018","unstructured":"Nalado AM, Mahlangu JN, Duarte R, Paget G, Olorunfemi G, Jacobson BF, et al. Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa. PLoS ONE. 2018;13:10.","journal-title":"PLoS ONE"},{"issue":"3","key":"2046_CR50","first-page":"399","volume":"52","author":"JY Xiang-Yang Li","year":"2014","unstructured":"Xiang-Yang Li JY, Li J-H, et al. Growth differentiation factor GDF-15 does not influence iron metabolism in stable chronic haemodialysis patients. Ann Clin Biochem. 2014;52(3):399\u2013403.","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"2046_CR51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1365-2141.2009.07961.x","volume":"148","author":"I Theurl","year":"2010","unstructured":"Theurl I, Finkenstedt A, Schroll A, Nairz M, Sonnweber T, Bellmann-Weiler R, et al. Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia. Br J Haematol. 2010;148(3):449\u201355.","journal-title":"Br J Haematol"},{"key":"2046_CR52","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12185-014-1626-7","volume":"100","author":"SWH Mei","year":"2014","unstructured":"Mei SWH, Fu R, et al. Hepcidin and GDF15 in anemia of multiple myeloma. Int J Hematol. 2014;100:266\u201373.","journal-title":"Int J Hematol"},{"key":"2046_CR53","first-page":"133","volume":"30","author":"M Omaima","year":"2015","unstructured":"Omaima M, Abbas MAH, Ashraf Y. El Fert, et al. growth differentiation factor 15 as a marker of ineffective erythropoesis in patients with chronic C virus infection. Menoufia Med J. 2015;30:133\u20138.","journal-title":"Menoufia Med J"},{"key":"2046_CR54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/JAHA.117.006225","volume":"6","author":"JJ De Haan","year":"2017","unstructured":"De Haan JJ, Haitjema S, den Ruijter HM, Pasterkamp G, de Borst GJ, Teraa M, et al. Growth Differentiation Factor 15 Is Associated With Major Amputation and Mortality in Patients With Peripheral Artery Disease. J Am Heart Assoc. 2017;6:9.","journal-title":"J Am Heart Assoc"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02046-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-02046-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02046-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T12:10:50Z","timestamp":1696767050000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02046-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2046"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02046-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.19401\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.19401\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.19401\/v3","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"12 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Human Research and Ethics Committee (HREC) of the University of the Witwatersrand, Johannesburg, South Africa; clearance certificate number 150929. All participants gave written informed consent before enrolment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no financial or non-financial competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"415"}}